Proof that tumor immunosurveillance by type I NKT cells occurs through CD1d became clear when adoptive transfer of liver DN type I NKT cells from WT into CD1d KO mice (lacking all NKT cells) did not confer protection. The gene discussed is CD1D; the disease is neoplasm.